DCF Advisers’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,100
| Closed | -$157K | – | 84 |
|
|
2021
Q2 | $157K | Sell |
13,100
-900
| -6% | -$10.8K | 0.06% | 75 |
|
|
2021
Q1 | $175K | Hold |
14,000
| – | – | 0.08% | 76 |
|
|
2020
Q4 | $218K | Sell |
14,000
-26,400
| -65% | -$411K | 0.09% | 69 |
|
|
2020
Q3 | $382K | Sell |
40,400
-30,000
| -43% | -$284K | 0.2% | 57 |
|
|
2020
Q2 | $631K | Buy |
70,400
+16,500
| +31% | +$148K | 0.35% | 42 |
|
|
2020
Q1 | $343K | Hold |
53,900
| – | – | 0.22% | 49 |
|
|
2019
Q4 | $451K | Buy |
+53,900
| New | +$451K | 0.29% | 42 |
|